Free Trial

Marshall Wace LLP Boosts Stock Position in Genpact Limited (NYSE:G)

Genpact logo with Business Services background

Marshall Wace LLP grew its holdings in shares of Genpact Limited (NYSE:G - Free Report) by 3,879.4% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 290,379 shares of the business services provider's stock after purchasing an additional 283,082 shares during the period. Marshall Wace LLP owned approximately 0.16% of Genpact worth $9,347,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the stock. Parallel Advisors LLC grew its stake in shares of Genpact by 22.6% in the fourth quarter. Parallel Advisors LLC now owns 1,882 shares of the business services provider's stock worth $65,000 after acquiring an additional 347 shares during the period. Cloverfields Capital Group LP grew its position in Genpact by 1.5% in the 1st quarter. Cloverfields Capital Group LP now owns 28,950 shares of the business services provider's stock worth $954,000 after purchasing an additional 416 shares during the period. United Services Automobile Association raised its stake in Genpact by 3.3% during the 2nd quarter. United Services Automobile Association now owns 13,388 shares of the business services provider's stock valued at $431,000 after buying an additional 433 shares during the last quarter. State of Michigan Retirement System lifted its holdings in shares of Genpact by 1.2% during the 1st quarter. State of Michigan Retirement System now owns 40,584 shares of the business services provider's stock valued at $1,337,000 after buying an additional 500 shares during the period. Finally, Moloney Securities Asset Management LLC boosted its stake in shares of Genpact by 2.0% in the 1st quarter. Moloney Securities Asset Management LLC now owns 27,236 shares of the business services provider's stock worth $897,000 after buying an additional 529 shares during the last quarter. 96.03% of the stock is owned by institutional investors.

Genpact Trading Up 1.2 %

NYSE G traded up $0.46 during trading on Monday, hitting $39.21. The stock had a trading volume of 1,031,078 shares, compared to its average volume of 1,376,442. The stock has a market capitalization of $7.06 billion, a price-to-earnings ratio of 11.15, a P/E/G ratio of 1.63 and a beta of 1.13. The stock has a 50 day simple moving average of $37.25 and a 200 day simple moving average of $34.07. Genpact Limited has a one year low of $29.41 and a one year high of $39.95. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.89 and a current ratio of 1.89.

Genpact (NYSE:G - Get Free Report) last issued its earnings results on Thursday, August 8th. The business services provider reported $0.69 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.64 by $0.05. The firm had revenue of $1.18 billion during the quarter, compared to analyst estimates of $1.15 billion. Genpact had a net margin of 14.12% and a return on equity of 22.28%. Sell-side analysts predict that Genpact Limited will post 2.85 earnings per share for the current year.

Genpact Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Wednesday, September 11th were given a dividend of $0.1525 per share. The ex-dividend date of this dividend was Wednesday, September 11th. This represents a $0.61 dividend on an annualized basis and a yield of 1.56%. Genpact's payout ratio is 17.43%.

Analyst Upgrades and Downgrades

G has been the subject of a number of research reports. TD Cowen upped their target price on shares of Genpact from $35.00 to $36.00 and gave the company a "hold" rating in a report on Friday, August 9th. JPMorgan Chase & Co. increased their price objective on shares of Genpact from $35.00 to $43.00 and gave the stock a "neutral" rating in a research note on Friday, September 6th. Jefferies Financial Group lifted their target price on shares of Genpact from $35.00 to $40.00 and gave the company a "hold" rating in a research note on Monday, September 9th. BMO Capital Markets increased their price target on Genpact from $38.00 to $42.00 and gave the stock a "market perform" rating in a research note on Monday, August 12th. Finally, Needham & Company LLC boosted their price objective on Genpact from $40.00 to $42.00 and gave the company a "buy" rating in a research report on Friday, August 9th. Eight equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, Genpact presently has an average rating of "Hold" and a consensus target price of $38.78.

Read Our Latest Stock Report on Genpact

About Genpact

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

See Also

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should you invest $1,000 in Genpact right now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Inflation-Busting Dividends: 3 Stocks Raising Payouts 4X Faster
Why Congress Is Betting Big on Chubb: The Underrated Insurance Stock
AST SpaceMobile Takes Major Leap in Global Connectivity with Satellite Launch

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines